Notice2023-10957
Agency Forms Undergoing Paperwork Reduction Act Review
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
May 23, 2023
Issuing agencies
Health and Human Services DepartmentCenters for Disease Control and Prevention
Full Text
<html>
<head>
<title>Federal Register, Volume 88 Issue 99 (Tuesday, May 23, 2023)</title>
</head>
<body><pre>
[Federal Register Volume 88, Number 99 (Tuesday, May 23, 2023)]
[Notices]
[Pages 33147-33148]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2023-10957]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[30Day-23-0920]
Agency Forms Undergoing Paperwork Reduction Act Review
In accordance with the Paperwork Reduction Act of 1995, the Centers
for Disease Control and Prevention (CDC) has submitted the information
collection request titled ``Data Collection Through Web Based Surveys
for Evaluating Act Against AIDS Social Marketing Campaign Phases
Targeting Consumers'' to the Office of Management and Budget (OMB) for
review and approval. CDC previously published a ``Proposed Data
Collection Submitted for Public Comment and Recommendations'' notice on
February 17, 2023 to obtain comments from the public and affected
agencies. CDC received two comments related to the previous notice.
This notice serves to allow an additional 30 days for public and
affected agency comments.
CDC will accept all comments for this proposed information
collection project. The Office of Management and Budget is particularly
interested in comments that:
(a) Evaluate whether the proposed collection of information is
necessary for the proper performance of the functions of the agency,
including whether the information will have practical utility;
(b) Evaluate the accuracy of the agencies estimate of the burden of
the proposed collection of information, including the validity of the
methodology and assumptions used;
(c) Enhance the quality, utility, and clarity of the information to
be collected;
(d) Minimize the burden of the collection of information on those
who are to respond, including, through the use of appropriate
automated, electronic, mechanical, or other technological collection
techniques or other forms of information technology, e.g., permitting
electronic submission of responses; and
(e) Assess information collection costs.
To request additional information on the proposed project or to
obtain a copy of the information collection plan and instruments, call
(404) 639-7570. Comments and recommendations for the proposed
information collection should be sent within 30 days of publication of
this notice to <a href="http://www.reginfo.gov/public/do/PRAMain">www.reginfo.gov/public/do/PRAMain</a>. Find this particular
information collection by selecting ``Currently under 30-day Review--
Open for Public Comments'' or by using the search function. Direct
written comments and/or suggestions regarding the items contained in
this notice to the Attention: CDC Desk Officer, Office of Management
and Budget, 725 17th Street NW, Washington, DC 20503 or by fax to (202)
395-5806. Provide written comments within 30 days of notice
publication.
Proposed Project
Data Collection Through Web Based Surveys for Evaluating Act
Against AIDS Social Marketing Campaign Phases Targeting Consumers (OMB
Control No. 0920-0920, Exp. 05/31/2023)--Extension--National Center for
HIV/AIDS, Viral Hepatitis, STD and TB Prevention (NCHHSTP), Centers for
Disease Control and Prevention (CDC).
Background and Brief Description
In response to the continued HIV epidemic in our country, in 2009
CDC launched the Let's Stop HIV Together campaign (formerly known as
Act Against AIDS), a multifaceted communication campaign to reduce HIV
incidence in the United States. CDC has released the campaign in
phases, with some of the phases running concurrently. Each phase of the
campaign uses mass media and direct-to-consumer channels to deliver
messages. Some campaigns provide basic education and increase awareness
of HIV/AIDS among the general public while others emphasize HIV
prevention and testing among specific subgroups or communities at
greatest risk of infection. CDC also develops new messages to address
changes in prevention science and subpopulations affected by HIV.
CDC has used a generic clearance (OMB No. 0920-0920) to facilitate
OMB approval of information collection needed to assess the
effectiveness of social marketing messages aimed at increasing HIV/AIDS
awareness, increasing prevention behaviors, and improving HIV testing
rates among consumers. Specifically, in 2022 CDC received OMB approval
to collect information for evaluating the acceptability and potential
effectiveness of proposed concepts, messages, and taglines for a
component of the Let's Stop HIV Together campaign (``Development of
Messages for the Let's Stop HIV Together National Campaign''). This
component emphasizes proven, effective prevention strategies, such as
pre-exposure prophylaxis (PrEP) and treatment as prevention (TasP).
Information collection has been initiated but has not been completed.
CDC is requesting OMB approval to extend the generic clearance and
to complete information collection that supports campaign development
and evaluation. Respondents will be recruited through national opt-in
email lists, the internet, and external partnerships with community-
based and membership organizations that work with or represent
individuals from targeted populations (e.g., National Urban League, the
National Medical Association).
To identify and reach target audiences, screening questions for up
to 30,880 potential respondents may address one or more of the
following items: Race/ethnicity, sexual behavior, sexual orientation,
gender identity, HIV testing history, HIV status, and injection drug
use. In addition, up to 5,445 respondents will be asked to complete a
self-administered survey at home on a personal computer. Each targeted
campaign survey will have a core set of items asked in all rounds, as
well as a module of questions relating to specific Let's Stop HIV
Together phases and activities.
OMB approval is requested for three years and there is no cost to
the respondents other than their time. The total estimated annualized
burden is 3,751 hours.
[[Page 33148]]
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Number of Average burden
Type of respondents Form name Number of responses per per response
respondents respondent (in hours)
----------------------------------------------------------------------------------------------------------------
Individuals (male and female) aged 18 Study Screener.......... 30,880 1 2/60
years and older.
Survey Module........... 5,445 1 30/60
----------------------------------------------------------------------------------------------------------------
Jeffrey M. Zirger,
Lead, Information Collection Review Office, Office of Public Health
Ethics and Regulations, Office of Science, Centers for Disease Control
and Prevention.
[FR Doc. 2023-10957 Filed 5-22-23; 8:45 am]
BILLING CODE 4163-18-P
</pre></body>
</html>Indexed from Federal Register on May 23, 2023.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.